Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.

Sci Rep 2017 04 21;7:46645. Epub 2017 Apr 21.

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep46645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399352PMC
April 2017
23 Reads

Publication Analysis

Top Keywords

gli1 acetylation
4
effects gli1
4
acetylation preclinical
4
preclinical models
4
shh medulloblastoma
4
models shh
4
elicits anticancer
4
anticancer effects
4
corrigendum selective
4
selective targeting
4
targeting hdac1/2
4
hdac1/2 elicits
4
effects
1
shh
1
medulloblastoma
1
models
1
targeting
1
hdac1/2
1
elicits
1
gli1
1

Similar Publications